198 related articles for article (PubMed ID: 32013538)
1. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
2. Targeted melanoma radiotherapy using ultrasmall
Zhang X; Chen F; Turker MZ; Ma K; Zanzonico P; Gallazzi F; Shah MA; Prater AR; Wiesner U; Bradbury MS; McDevitt MR; Quinn TP
Biomaterials; 2020 May; 241():119858. PubMed ID: 32120314
[TBL] [Abstract][Full Text] [Related]
3. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
Chen F; Zhang X; Ma K; Madajewski B; Benezra M; Zhang L; Phillips E; Turker MZ; Gallazzi F; Penate-Medina O; Overholtzer M; Pauliah M; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Quinn TP
ACS Appl Mater Interfaces; 2018 Feb; 10(5):4379-4393. PubMed ID: 29058865
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and Multicompartment Pharmacokinetic Analysis of a Targeted α Particle Therapy.
Tichacek CJ; Tafreshi NK; Kil H; Engelman RW; Doligalski ML; Budzevich MM; Gage KL; McLaughlin ML; Wadas TJ; Silva A; Moros E; Morse DL
Mol Pharm; 2020 Nov; 17(11):4180-4188. PubMed ID: 32960613
[TBL] [Abstract][Full Text] [Related]
5. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
6. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor immune response varies among individuals: A gene expression profiling of mouse melanoma.
Yang X; Ma Z; Zhang Y; Wu J; Huang J; Zhao W; Mo F; Lin Z; Xu Y; Zhou Z; Chen S
Int Immunopharmacol; 2020 Mar; 80():106211. PubMed ID: 31972424
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
9. Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
Henriksen G; Schoultz BW; Michaelsen TE; Bruland ØS; Larsen RH
Nucl Med Biol; 2004 May; 31(4):441-9. PubMed ID: 15093814
[TBL] [Abstract][Full Text] [Related]
10. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
[No Abstract] [Full Text] [Related]
11. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
Benezra M; Penate-Medina O; Zanzonico PB; Schaer D; Ow H; Burns A; DeStanchina E; Longo V; Herz E; Iyer S; Wolchok J; Larson SM; Wiesner U; Bradbury MS
J Clin Invest; 2011 Jul; 121(7):2768-80. PubMed ID: 21670497
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
[TBL] [Abstract][Full Text] [Related]
13. Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Madajewski B; Chen F; Yoo B; Turker MZ; Ma K; Zhang L; Chen PM; Juthani R; Aragon-Sanabria V; Gonen M; Rudin CM; Wiesner U; Bradbury MS; Brennan C
Clin Cancer Res; 2020 Oct; 26(20):5424-5437. PubMed ID: 32723835
[TBL] [Abstract][Full Text] [Related]
14. BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment.
Liu W; Stachura P; Xu HC; Váraljai R; Shinde P; Ganesh NU; Mack M; Van Lierop A; Huang A; Sundaram B; Lang KS; Picard D; Fischer U; Remke M; Homey B; Roesch A; Häussinger D; Lang PA; Borkhardt A; Pandyra AA
Cancer Res; 2022 Jan; 82(2):264-277. PubMed ID: 34810198
[TBL] [Abstract][Full Text] [Related]
15. Calcium Carbonate Core-Shell Particles for Incorporation of
Muslimov AR; Antuganov DO; Tarakanchikova YV; Zhukov MV; Nadporojskii MA; Zyuzin MV; Timin AS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25599-25610. PubMed ID: 34028266
[TBL] [Abstract][Full Text] [Related]
16. Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.
Chen J; Cao Y; Markelc B; Kaeppler J; Vermeer JA; Muschel RJ
J Clin Invest; 2019 Oct; 129(10):4224-4238. PubMed ID: 31483286
[TBL] [Abstract][Full Text] [Related]
17. Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Kheshti AMS; Hajizadeh F; Barshidi A; Rashidi B; Ebrahimi F; Bahmanpour S; Karpisheh V; Noukabadi FK; Kiani FK; Hassannia H; Atyabi F; Kiaie SH; Kashanchi F; Navashenaq JG; Mohammadi H; Bagherifar R; Jafari R; Zolbanin NM; Jadidi-Niaragh F
Pharm Res; 2022 Feb; 39(2):353-367. PubMed ID: 35166995
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
Xu Z; Wang Y; Zhang L; Huang L
ACS Nano; 2014 Apr; 8(4):3636-45. PubMed ID: 24580381
[TBL] [Abstract][Full Text] [Related]
19. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H
Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808
[TBL] [Abstract][Full Text] [Related]
20. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
